Certara & ichnos glenmark innovation collaboration optimizes dosing strategy for potential first-in-class cancer drug

Certara shared the results from its collaboration with ichnos glenmark innovation (igi) on the first-in-human dose prediction and selection for isb 2001.

CERT Ratings Summary

CERT Quant Ranking